Coronavirus

Champaign, IL — A new study shows that it is possible to use the genetic sequences of a person’s antibodies to predict what pathogens those antibodies will target. Reported in the journal Immunity, the new approach successfully differentiates between antibodies against influenza and those attacking SARS-CoV-2, the virus that causes COVID-19. “Our research is in […]

Durham, NC — The virus that causes COVID-19, SARS-CoV-2, can directly infect a specialized type of kidney cell. The discovery helps explain why acute kidney injury is one of the main complications observed in patients with severe COVID-19, according to biomedical engineers and virologists at Duke University. The research appeared online April 20 in the […]

Los Angeles, CA — New UCLA research finds that 30% of people treated for COVID-19 developed Post Acute Sequelae of COVID-19 (PASC), most commonly known as “Long COVID.” People with a history of hospitalization, diabetes, and higher body mass index were most likely to develop the condition, while those covered by Medicaid, as opposed to […]

Irvine, CA — A new study, led by researchers from the University of California, Irvine, identifies a reason for why older adults are significantly more susceptible to infectious diseases than younger people, a critical societal issue most recently exemplified by the COVID-19 pandemic. Study results also pave the way for new potential therapeutic targets to […]

Osaka, Japan — Liver disease negatively impacted by lifestyle changes during the first year of the pandemic, according to a new study in the journal Liver International. The retrospective study used health checkup data of 973 participants between 2018 and 2020 from MedCity21, an advanced medical centre for preventive medicine established by Osaka City University […]

Huddersfield, UK — Huddersfield researchers were among the first to demonstrate how the induction of brain inflammation accounts for neurological damage in COVID19 patients and now, their findings have been published in the peer-reviewed medical journal Molecular Neurobiology. The study, led by the University of Huddersfield’s Dr. Mayo Olajide, describes how the spike protein used […]

Evanston, IL — A small preliminary study from Northwestern Medicine has shown that a blood test may identify risk of stillbirth and placentitis in pregnant individuals who have had COVID-19. The finding builds on another study with similar results and could have implications in how physicians screen for and address high-risk pregnancies. Research has shown […]

Baton Rouge, LA – While no medically recognized treatment exists for Long COVID, exercise may break the vicious cycle of inflammation that can lead to developing diabetes and depression months after a person recovers from the virus. “We know that Long COVID causes depression, and we know that it can increase blood glucose levels to […]

New York, NY — Maintaining face mask use in public indoor spaces and on public transportation for at least two weeks after COVID-19 vaccination targets (with a minimum of 70%) are met is cost-effective, typically cost-saving, and saves lives, according to a modelling study published in The Lancet Public Health journal. The lower the level […]

Quebec City, Canada — Professor Charles Ramassamy and his postdoctoral researcher Mohamed Haddad at  Institut national de la recherche scientifique (INRS), in collaboration with scientists from Université de Montréal, McGill University, and Université du Québec à Montréal (UQAM), believe that tannic acid plays a role in inhibiting three important molecular pathways involved in the SARS-CoV-2 […]

Los Alamos, NM — New computer models and simulations from Los Alamos National Laboratory are showing researchers how the virus that causes COVID-19 manages to use its spike protein to fuse with and infect human cells. To be presented at the March meeting of the American Physical Society, the atomistic-level imagery is highly consistent with […]

San Francisco, CA — The SARS-CoV-2 virus is continuously evolving and structural changes to the virus may impact the efficacy of antibody therapies and vaccines. A study publishing February 17th in PLOS Pathogens by Anshumali Mittal at the University of Pittsburgh, USA and colleagues describes the structural and functional landscape of neutralizing antibodies against SARS-CoV-2 […]